AlphaYouJR
Insider selling
Jennifer Riley sold $52K of Avalo Therapeutics, Inc. (AVTX) stock
Jennifer Riley, Chief Strategy Officer of Avalo Therapeutics, Inc. (AVTX), sold 2,655 shares of AVTX stock worth $52K, per an SEC Form 4 filed Aug 12, 2026.
It was an open-market sale.
The trade happened on Aug 11, 2026, 1 day before it was made public.
AVTX has moved -15.2% since the trade date, from $19.47 to $16.51 (Sep 22, 2026 close).
- Traded
- Aug 11, 2026
- Disclosed
- Aug 12, 2026
- Filing delay
- 1 day
- Price since
- -15.2%
- Role
- Chief Strategy Officer
- Source
- SEC Form 4
More AVTX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.